Figure 1. Study design for the in vivo study in nude mice. A: Dosage-dependent safety and toxicity. B: Dosage efficacy study. The HuCCT-1 xenografted nude mice were initially planned to receive 6 treatments. Since the G1 group (no treatment group) however showed poor status with a significant tumor growth, 6th treatment was omitted.